APOE and Alzheimer disease: Together, these findings illuminate how peripheral and central tissue environments modulate APOE ε4-driven immune responses, provide new mechanistic insight into AD pathogenesis, and support the development of precision biomarkers and immunomodulatory interventions targeting early-stage disease processes.